Stephen Olson
Grants and Patents
Grants and Patents
Selected Grants
Award: A Randomized, Double-Blind, Placebo Controlled, Fixed Do
Principal Investigator: Olson, Stephen Craig
Sponsoring Organization: AUSPEX PHARMACEUTICALS, INC
Award Dates: 2014 - 2015
Award: An Open-Label, Long-Term Safety Study of SD-809 (Dutetra
Principal Investigator: Olson, Stephen Craig
Sponsoring Organization: AUSPEX PHARMACEUTICALS, INC
Award Dates: 2014 - 2016
Award: A Randomized, Double-Blind, Placebo-Controlled Study of
Principal Investigator: Olson, Stephen Craig
Sponsoring Organization: AUSPEX PHARMACEUTICALS, INC
Award Dates: 2014 - 2015
Award: Management of Schizophrenia in Clinical Practice (MOSAIC
Principal Investigator: Olson, Stephen Craig
Sponsoring Organization: GENENTECH, INC.
Award Dates: 2013 - 2014
Award: Management of Schizophrenia in Clinical Practice (MOSAIC
Principal Investigator: Olson, Stephen Craig
Sponsoring Organization: GENENTECH, INC.
Award Dates: 2013 - 2014
Award: A Multicenter, Open-label Study to Assess Hospitalizatio
Principal Investigator: Olson, Stephen Craig
Sponsoring Organization: COVANCE INC.
Award Dates: 2012 - 2014
Award: Clinical and Biomarker Assessment of Efficacy of Cogniti
Principal Investigator: Olson, Stephen Craig
Sponsoring Organization: RESEARCH FOUNDATION FOR MENTAL HYGIENE
Award Dates: 2011 - 2013
Award: A Randomized, Double-Blind, Placebo-Controlled, Parallel
Principal Investigator: Olson, Stephen Craig
Sponsoring Organization: ABBOTT LABORATORIES
Award Dates: 2010 - 2011
Award: Proteomic Diagnostic Test for Schizophrenia
Principal Investigator: Schulz, Sellmann Charles
Sponsoring Organization: Rules-Based Medicine, Inc
Award Dates: 2010 - 2015
Award: A Study of Varenicline for Prevention of Relapse to Smok
Principal Investigator: Mooney, Marc Edward
Sponsoring Organization: MASSACHUSETTS GENERAL HOSPITAL
Award Dates: 2010 - 2011
Award: Varenicline and Smoking Cessation in Schizophrenia
Principal Investigator: Fatemi, Seyyed Hossein
Sponsoring Organization: NIH NIDA NATL INST ON DRUG AB
Award Dates: 2009 - 2012
Award: Effectiveness of Antipsychotic Medications (Clinical Ant
Principal Investigator: Olson, Stephen Craig
Sponsoring Organization: THE UNIV OF N CAROLINA AT CHAPEL HILL
Award Dates: 2008 - 2010
Award: Effectiveness of Antipsychotic Medications (Clinical Ant
Principal Investigator: Olson, Stephen Craig
Sponsoring Organization: THE UNIV OF N CAROLINA AT CHAPEL HILL
Award Dates: 2008 - 2010
Award: AstraZeneca D3450-HALO Study
Principal Investigator: Olson, Stephen Craig
Sponsoring Organization: ASTRAZENECA
Award Dates: 2007 - 2009
Award: A Randomized, Multicenter, Double-blind, Parallel Group
Principal Investigator: Olson, Stephen Craig
Sponsoring Organization: SOLVAY PHARM
Award Dates: 2007 - 2009
Award: Sanofi-Aventis DR16726 Cognitive Impairment in Schizophr
Principal Investigator: Olson, Stephen Craig
Sponsoring Organization: SANOFI-AVENTIS US
Award Dates: 2007 - 2009
Award: Validation of the Reasons for Antipsychotic Discontinuat
Principal Investigator: Olson, Stephen Craig
Sponsoring Organization: UNITED BIOSOURCE CORPORATION
Award Dates: 2007 - 2008
Award: A Multi-Center, Open-Label, Parallel-Group, Randomized,
Principal Investigator: Olson, Stephen Craig
Sponsoring Organization: SOLVAY PHARM
Award Dates: 2006 - 2008
Award: CAMP - Clinical Assessment of Metabolic Problems
Principal Investigator: Olson, Stephen Craig
Sponsoring Organization: THE UNIV OF N CAROLINA AT CHAPEL HILL
Award Dates: 2006 - 2010
Award: MASTER: CAMP - Clinical Assessment of Metabolic Problems
Principal Investigator: Olson, Stephen Craig
Sponsoring Organization: THE UNIV OF N CAROLINA AT CHAPEL HILL
Award Dates: 2006 - 2008
Award: A Randomized, Parallel Group, Multiple Dose, 6-week Stud
Principal Investigator: Olson, Stephen Craig
Sponsoring Organization: ORGANON PHARM INC
Award Dates: 2006 - 2008
Award: A Randomized, Parallel Group, Multiple Dose, 6-week Stud
Principal Investigator: Olson, Stephen Craig
Sponsoring Organization: ORGANON PHARM INC
Award Dates: 2006 - 2008
Award: Effectiveness of Switching Antipsychotic Medications
Principal Investigator: Olson, Stephen Craig
Sponsoring Organization: THE UNIV OF N CAROLINA AT CHAPEL HILL
Award Dates: 2006 - 2009
Award: Multicenter, Double-Blind, Flexible-Dose, 6-Month Extens
Principal Investigator: Olson, Stephen Craig
Sponsoring Organization: IQVIA, INC
Award Dates: 2006 - 2008
Award: Multicenter, Double-Blind, Flexible-Dose, 6-Month Trial
Principal Investigator: Olson, Stephen Craig
Sponsoring Organization: IQVIA, INC
Award Dates: 2006 - 2008
Award: A randomized, placebo-controlled, double-blind trial of
Principal Investigator: Olson, Stephen Craig
Sponsoring Organization: IQVIA, INC
Award Dates: 2006 - 2008
Award: A randomized, placebo-controlled, double-blind trial of
Principal Investigator: Olson, Stephen Craig
Sponsoring Organization: IQVIA, INC
Award Dates: 2006 - 2007
Award: Efficacy and Safety of Bifeprunox in the Treatment of Sc
Principal Investigator: Olson, Stephen Craig
Sponsoring Organization: IQVIA, INC
Award Dates: 2004 - 2008
Award: Efficacy and Safety of Bifeprunox in the Treatment of Sc
Principal Investigator: Olson, Stephen Craig
Sponsoring Organization: IQVIA, INC
Award Dates: 2004 - 2006
Award: Efficacy and Safety of Bifeprunox in the Treatment of Sc
Principal Investigator: Olson, Stephen Craig
Sponsoring Organization: IQVIA, INC
Award Dates: 2004 - 2008
Award: Efficacy and Safety of Bifeprunox in the Treatment of Sc
Principal Investigator: Olson, Stephen Craig
Sponsoring Organization: IQVIA, INC
Award Dates: 2004 - 2006
Award: A multicenter, open-label, flexible-dose, parallel-group
Principal Investigator: Olson, Stephen Craig
Sponsoring Organization: ASTRAZENECA
Award Dates: 2003 - 2008
Award: Effectiveness of Antipsychotic Medications (Clinical Ant
Principal Investigator: Olson, Stephen Craig
Sponsoring Organization: THE UNIV OF N CAROLINA AT CHAPEL HILL
Award Dates: 2002 - 2010
Award: Effectiveness of Antipsychotic Medications (Clinical Ant
Principal Investigator: Olson, Stephen Craig
Sponsoring Organization: THE UNIV OF N CAROLINA AT CHAPEL HILL
Award Dates: 2002 - 2010
Award: White Matter Abnormalities in Schizophrenia
Principal Investigator: Lim, Kelvin O
Sponsoring Organization: NIH Nat'l Institute of Mental Health
Award Dates: 1999 - 2012
Contact
Contact
Address
Riverside West 274-32450 Riverside Avenue
Minneapolis, MN 55454